Evotec SE (OTCMKTS:EVTCY – Get Free Report)’s stock price reached a new 52-week low on Monday . The stock traded as low as $2.90 and last traded at $2.96, with a volume of 199176 shares changing hands. The stock had previously closed at $3.14.
Evotec Stock Down 2.0 %
The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50. The firm’s 50 day moving average is $3.38 and its two-hundred day moving average is $4.68. The firm has a market capitalization of $957.64 million, a P/E ratio of 7.07 and a beta of 0.98.
Evotec Company Profile
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Read More
- Five stocks we like better than Evotec
- What is a Death Cross in Stocks?
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Insider Buying Explained: What Investors Need to Know
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.